Levothyroxine Sodium Tablets recall
FDA recall D-0702-2026 · initiated Jul 13, 2026
Major Pharmaceuticals recalled Levothyroxine Sodium Tablets in Jul 2026 — an FDA Class II recall (D-0702-2026) because Subpotent Drug.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Subpotent Drug
Wrong strength, or it did not keep
The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: N/A
Details
- Product
- Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61
- Recalling company
- Major Pharmaceuticals
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide in the USA.
- Initiated
- Jul 13, 2026
- FDA report date
- Jul 29, 2026
This recall is linked to a product we cover: Levothyroxine Sodium →
Frequently asked
- Was Levothyroxine Sodium Tablets recalled?
- Major Pharmaceuticals recalled Levothyroxine Sodium Tablets in Jul 2026 — an FDA Class II recall (D-0702-2026) because Subpotent Drug. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Levothyroxine Sodium Tablets recalled?
- Per the FDA enforcement record, the reason for recall D-0702-2026 was: Subpotent Drug
- Is a recalled Levothyroxine Sodium Tablets dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Levothyroxine Sodium Tablets are affected?
- Distributed: Nationwide in the USA.. The recall covers these lots — Lot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0702-2026.